Fernando Riesgo Gil
Overview
Explore the profile of Fernando Riesgo Gil including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fiorelli F, Panoulas V, Riesgo Gil F, Era C, Rosenberg A
Eur Heart J Case Rep
. 2024 May;
8(5):ytae151.
PMID: 38751900
Background: The use of mechanical circulatory support (MCS) has markedly increased over the last decade, so have the inter-hospital transfers, with the aim of being able to offer advanced heart...
2.
Gallone G, Ibero J, Morley-Smith A, Monteagudo Vela M, Fiorelli F, Konicoff M, et al.
J Am Heart Assoc
. 2024 Apr;
13(9):e032617.
PMID: 38686903
Background: We evaluated the potential benefits of renin-angiotensin-aldosterone system inhibitors (RAASi) in patients with left ventricular assist device support. Methods And Results: A total of 165 consecutive patients undergoing left...
3.
Akhtar W, Baston V, Berman M, Bhagra S, Chue C, Deakin C, et al.
Intensive Care Med
. 2024 Mar;
50(4):493-501.
PMID: 38526578
An implantable left ventricular assist device (LVAD) is indicated as a bridge to transplantation or recovery in the United Kingdom (UK). The mechanism of action of the LVAD results in...
4.
5.
Akhtar W, Butcher C, Morley-Smith A, Riesgo Gil F, Dar O, Baston V, et al.
ESC Heart Fail
. 2022 Jul;
9(6):4340-4343.
PMID: 35906098
Aims: We present a single-centre retrospective experience using oral milrinone in patients with a left ventricular assist device (LVAD) and concurrent refractory right ventricular failure. Methods And Results: All patients...
6.
Akhtar W, Gamble B, Kiff K, Wypych-Zych A, Raj B, Takata J, et al.
Resusc Plus
. 2022 Jun;
10:100254.
PMID: 35669526
Background: Published guidance concerning emergency management of left ventricular assist device (LVAD) recipients is both limited and lacking in consensus which increases the risk of delayed and/or inappropriate actions. Methods:...
7.
Brida M, Lovric D, Griselli M, Riesgo Gil F, Gatzoulis M
Int J Cardiol
. 2022 Mar;
357:39-45.
PMID: 35283250
Heart failure (HF) represents the leading cause of morbidity and mortality in adult patients with congenital heart disease. The nature of underlying congenital heart disease has bearing on timing and...
8.
Rajani P, Robertus J, Wong J, Homfray T, Riesgo Gil F, Shanmuganathan M
JACC Case Rep
. 2021 Jul;
2(5):760-763.
PMID: 34317343
A young man presented with syncope. He was diagnosed with triglyceride deposit cardiomyovasculopathy and skeletal myopathy secondary to adipose triglyceride lipase (ATGL) deficiency. Despite optimal medical therapy, he required heart ...
9.
Monteagudo Vela M, Baston V, Panoulas V, Riesgo Gil F, Simon A
Interact Cardiovasc Thorac Surg
. 2020 Nov;
32(2):298-305.
PMID: 33236054
Objectives: Left ventricular assist device (LVAD) implantation for end-stage heart failure patients has been on the rise, providing a reliable long-term option. For some LVAD patients, longer term LV unloading...
10.
Monteagudo Vela M, Simon A, Riesgo Gil F, Rosenberg A, Dalby M, Kabir T, et al.
Cardiovasc Revasc Med
. 2019 Dec;
21(5):629-637.
PMID: 31859100
Introduction: The Impella family of devices are short-term mechanical circulatory support (MCS) pumps that hold promise in treating patients with acute cardiogenic shock, acting as bridge to recovery, transplant or...